Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors
X. Wang, S. Su, Y. Zhu, X. Cheng, C. Chen, L. Chen, A. Lei, L. Zhang, Y. Xu, W. Li, Y. Zhang, D. Ye, J. ZHANG
This study shows that targeting ACOD1 enhances the pro-inflammatory state and anti-tumor activity of human CAR-iMACs in solid tumors.
bioRxiv · Apr 20, 2023 · PreprintImmunology